Tuberculosis treatment is expensive for patients in developing countries.

Bevan, E

Tuberculosis treatment is expensive for patients in developing countries. [electronic resource] - BMJ (Clinical research ed.) Jul 1997 - 187-8 p. digital

Publication Type: Comment; Letter

0959-8138

10.1136/bmj.315.7101.187a doi


Antitubercular Agents--economics
Developing Countries
Drug Costs
Health Care Costs
Humans
Tuberculosis--drug therapy